The Center for Technology Licensing's (CTL) mission is to bring the University's scientific discoveries, technological innovations, and medical advances to the marketplace for societal benefit and to foster economic development within New York State and across the nation.
Licensing
CTL is industry's link to Cornell's broad range of innovative research that is available for licensing. Over the years, Cornell technologies have been licensed to industry partners all over the world in support of Cornell's land-grant mission and to develop these technologies and plant varieties into products and services for public good.
Available Cornell Technologies
- Novel method for 3D imaging of whole tissues
- Reactive Ion Etching of Barium Stannate
- CDCP1 as a Novel Therapeutic Target for Cancer Therapy
- Local and Continuous Delivery of a Mast Cell Stabilizer During Wound Healing to Reduce Fibrotic Scarring
- Single Sperm Sequencing Assay for Prediction of Autism Risk and as a Substitute for Manual Sperm Analysis
- Pumpless, Unidirectional, and Multiorgan Microfluidic Platform for Preclinical Drug Testing
Current Featured Technologies
- » Biomarkers for Predicting & Diagnosing Cancer/Metastasis
- » Reversible Small Molecule Immunoproteasome Inhibitors
- » Tethered Enzyme Technology (TET™) Point-of-Care Testing for Brain Injuries
- » Red Wine Grape ‘Arandell’
- » White Wine Grape ‘Aromella’
- » Accommodating Intraocular Lens & Conversion Plate
- » Generic Programmable Tag